SF4089 (Legislative Session 94 (2025-2026))
Vaccine administration education and training requirements to prevent shoulder injuries related to vaccine administration establishment and appropriation
Related bill: HF3880
AI Generated Summary
Purpose
- Establish and standardize education, training, and display requirements to prevent shoulder injuries related to vaccine administration (SIRVA) and broaden who can administer vaccines, with a focus on improving safety and consistency for vaccine delivery.
Key Provisions
SIRVA definition and prevention materials
- Defines SIRVA (shoulder injury related to vaccine administration) as described in federal regulations.
- Requires every health care setting that administers vaccines (clinics, pharmacies, etc.) to display a poster about proper vaccine administration techniques to prevent SIRVA. The poster must be visible to the public and all vaccine administrators.
Training for vaccine administration
- Beginning July 1, 2026, health care personnel who administer vaccines must complete comprehensive, competency-based training on vaccine administration.
- Training must follow Centers for Disease Control and Prevention (CDC) guidance and cover topics such as vaccine preparation, needle selection, site and route of administration, and SIRVA as a potential serious complication.
- After completing training, health care personnel must submit evidence of completion to the relevant health licensing board.
Exceptions
- The SIRVA training and poster requirements do not apply to veterinary clinics, veterinary hospitals, licensed veterinarians, or licensed veterinary technicians.
Expanded vaccine administration by dentists
- Qualified dentists may administer vaccines to patients age 16 and older, but only if they have immediate access to emergency equipment (like oxygen and epinephrine) and have completed a Board-approved vaccine administration education program (per Minnesota Board of Dentistry) that meets 145.676 subdivision 3 requirements.
- The dentist training program must include topics such as disease and vaccination education, contraindications and precautions, intramuscular administration, risk/benefit communication, adverse event reporting, federal documentation, and vaccine storage/handling.
- Dentists giving vaccines must follow guidelines from the federal Advisory Committee on Immunization Practices (ACIP) related to vaccines and immunizations.
Expanded role and duties for pharmacists
- Pharmacists may initiate, order, and administer influenza and COVID-19 vaccines to all eligible individuals age 3 and older, and all other FDA-approved vaccines to patients age 6 and older, per ACIP recommendations.
- Pharmacists who administer vaccines must complete training that meets 145.676 subdivision 3 requirements.
- Pharmacy technicians or pharmacy interns may administer vaccines under the direct supervision of a pharmacist, provided they complete ACPE-approved immunization training or an approved program, and other conditions (e.g., MIIC use to check immunization status, age-specific counseling, and reporting).
- Pharmacists may delegate certain vaccine-related tasks to trained technicians or interns if specific supervision, reporting, and documentation requirements are met (including use of the Minnesota Immunization Information Connection, MIIC).
- Additional supervision and safety conditions apply for technicians administering vaccines (in-person supervision, immediate pharmacist availability, CPR certification, CE requirements, and specific training program approvals).
- Pharmacists may also:
- Initiate, order, and administer other therapies under protocols or collaborative practice agreements with other licensed prescribers (doctors, dentists, optometrists, podiatrists, veterinarians, or nurse practitioners) for disease prevention, treatment, and follow-up.
- Document any changes to therapy in the patient’s medical record or report to the treating practitioner.
- Engage in a range of pharmacy practice activities, including drug storage, record-keeping, patient counseling, and other services necessary for safe and effective drug use.
- Expanded categories include administering and managing various therapies (such as certain HIV-related therapies and other medications) under protocol or collaborative practice agreements, following applicable rules and documentation requirements.
Coordination and reporting
- When vaccines are administered under these expanded authorities, required documentation and reporting to appropriate records and practitioners are mandated.
- Use of MIIC to assess immunization status is required for vaccine administration by pharmacists, with certain age-based exceptions (e.g., influenza vaccines for ages 9 and older may have an exception to MIIC use).
Administrative and professional requirements
- Vaccinators must complete and maintain required certifications (CPR, ACPE-approved immunization CE, etc.) and operate under approved programs or protocols.
- Records management and documentation requirements apply to changes in drug therapy and vaccine administration.
Appropriation for SIRVA poster
- A one-time appropriation in FY 2027 from the general fund to the Minnesota Department of Health to create or approve a SIRVA prevention poster and make it available for display in all settings where vaccines are given.
Implementation Timeline and Funding
- July 1, 2026: Start date for the comprehensive vaccine administration training requirement for health care personnel.
- Fiscal Year 2027: One-time general fund appropriation to fund the SIRVA prevention poster program and its dissemination.
Significant Changes to Existing Law
- Adds a mandatory SIRVA prevention poster requirement in all vaccine- administering settings.
- Establishes a mandatory competency-based vaccine administration training requirement for health care personnel post-July 1, 2026.
- Expands vaccine administration authority to qualified dentists (16+ with proper training and emergency equipment) and broadens pharmacist authority to administer vaccines to a wider age group and under protocols with other health professionals.
- Introduces detailed supervision, reporting, and education requirements for pharmacy technicians/interns who administer vaccines.
- Codifies extensive protocol-based and collaborative-practice-based approaches for initiating, modifying, and discontinuing certain drug therapies in collaboration with multiple licensed professionals.
- Creates a dedicated funding mechanism for educational materials (SIRVA poster) to support dissemination and awareness.
Overall Impact
- Aims to reduce vaccine-related shoulder injuries through standardized training and visible safety materials.
- Improves access to vaccination by expanding qualified professionals who can administer vaccines (dentists and pharmacists) while emphasizing safety, training, and documentation.
- Enhances coordination among health professionals through protocols and reporting requirements to promote safe vaccine and drug therapy practices.
Relevant Terms - SIRVA (shoulder injury related to vaccine administration) - vaccine administration - CDC guidance - ACIP (Advisory Committee on Immunization Practices) - ACPE (Accreditation Council for Pharmacy Education) - MIIC (Minnesota Immunization Information Connection) - vaccine storage and handling - immunization reporting - pharmacist scope of practice - pharmacist-administered vaccines - vaccine administration training - competency-based training - influenza vaccine - COVID-19 vaccine / SARS-CoV-2 vaccine - dental vaccination - emergency equipment (e.g., oxygen, epinephrine) - CDC-defined vaccine administration site and route - vaccine-related protocols and collaborative practice agreements - well-child visit counseling - CPR certification - post-implementation funding for SIRVA poster - health care setting display requirements - federal regulations and guidelines ( CFR, 42 U.S.C. references)
Bill text versions
- Introduction PDF PDF file
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 04, 2026 | Senate | Action | Introduction and first reading | ||
| March 04, 2026 | Senate | Action | Referred to | Health and Human Services |
Citations
[
{
"analysis": {
"added": [
"Dentists may administer vaccines to patients 16 years and older if they have immediate access to emergency equipment.",
"Training program approved by the Minnesota Board of Dentistry that complies with 145.676, subdivision 3.",
"Training content requirements (disease/vaccination education, contraindications, intramuscular administration, risk/benefits, adverse events, federal reporting, storage/handling).",
"Guidelines from federal ACIP (as applicable)."
],
"removed": [],
"summary": "Amends Minnesota Statutes 2024, section 150A.055, subdivision 2 to authorize licensed dentists to administer vaccines to eligible patients (16+) under specified conditions, and to require training that complies with section 145.676, subdivision 3, including content on disease prevention, contraindications, intramuscular administration, risk/benefits, adverse event reporting, and vaccine storage/handling; practitioner must follow federal CLIA/CDC guidelines.",
"modified": []
},
"citation": "150A.055",
"subdivision": "subdivision 2"
},
{
"analysis": {
"added": [
"Clinically testing within pharmacy practice, including interpretation of waived CLIA tests.",
"Pharmacists may collect specimens, interpret results, notify patients, and refer to other providers as needed.",
"Pharmacists may initiate, modify, or discontinue drug therapy pursuant to a protocol or collaborative practice agreement.",
"Pharmacists may delegate test administration to a pharmacy technician or intern under direct supervision, with conditions.",
"Increased scope for drug therapy management, vaccine administration, and therapeutic device selection under protocols or CPAs.",
"Medications for preventing HIV acquisition and other therapies under CPAs or protocols; documentation in medical records.",
"Requirements for vaccination-related activities, including storage, administration, and reporting."
],
"removed": [],
"summary": "Amends Minnesota Statutes 2024, section 151.01, subdivision 27, to redefine the practice of pharmacy and expand pharmacists' authority, including testing and vaccine administration, collaboration with other providers, and documentation requirements.",
"modified": [
"Broadens the scope of pharmacy practice to include CLIA-waived testing and expanded vaccine administration responsibilities.",
"Requires documentation in patient records and reporting to the responsible practitioner."
]
},
"citation": "151.01",
"subdivision": "subdivision 27"
},
{
"analysis": {
"added": [
"SIRVA is defined using CFR 42 §100.3(c)(10) or equivalent.",
"Foundation for the subsequent poster and training requirements."
],
"removed": [],
"summary": "Establishes definitions for SIRVA (shoulder injury related to vaccine administration) in accordance with CFR, within the SIRVA Prevention Activities section of Minnesota Statutes.",
"modified": []
},
"citation": "145.676",
"subdivision": "subdivision 1"
},
{
"analysis": {
"added": [
"Poster that describes proper vaccine administration techniques to prevent SIRVA.",
"Poster to be created or approved by the Commissioner of Health and displayed in locations accessible to the public and health care personnel."
],
"removed": [],
"summary": "Requires SIRVA prevention poster in health care settings where vaccines are administered.",
"modified": []
},
"citation": "145.676",
"subdivision": "subdivision 2"
},
{
"analysis": {
"added": [
"Comprehensive competency-based training on vaccine administration for vaccine-eligible health care personnel.",
"Training must conform to CDC guidance and cover vaccine preparation, needle selection, site/route selection, administration, and SIRVA risk.",
"Health care personnel must submit evidence of completion to the health-related licensing board."
],
"removed": [],
"summary": "Requires competency-based training for vaccine administration by health care personnel who administer vaccines after July 1, 2026; training must align with CDC guidance.",
"modified": []
},
"citation": "145.676",
"subdivision": "subdivision 3"
},
{
"analysis": {
"added": [
"Exceptions for veterinary settings and credentialed veterinarians/technicians."
],
"removed": [],
"summary": "Provides exceptions to the SIRVA prevention provisions for veterinary clinics, hospitals, licensed veterinarians or licensed veterinary technicians.",
"modified": []
},
"citation": "145.676",
"subdivision": "subdivision 4"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References to section 151.37 subdivision 13 within the context of protocols for opiate antagonist therapy or related prescribing practices.",
"modified": [
"Connects opiate antagonist protocol allowances to CPAs or prescribed protocols with specific health professionals."
]
},
"citation": "151.37",
"subdivision": "subdivision 13"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References to subsection 14 related to prescribing self-administered hormonal contraceptives, nicotine replacement therapy, and opiate antagonists for acute opiate overdose.",
"modified": [
"Expands pharmacist authority to prescribe or administer specified medications under protocols or CPAs."
]
},
"citation": "151.37",
"subdivision": "subdivision 14"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References to subsection 15 related to prescribing, dispensing, or administering certain medications under protocol or CPA frameworks.",
"modified": [
"Expands pharmacist authority to prescribe or administer specified medications under protocols or CPAs."
]
},
"citation": "151.37",
"subdivision": "subdivision 15"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References to subsection 16 related to opiate antagonists and related therapies within pharmacist practice.",
"modified": [
"Expands pharmacist authority to prescribe or administer specified medications under protocols or CPAs."
]
},
"citation": "151.37",
"subdivision": "subdivision 16"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References to section 151.37 subdivision 17 related to HIV prevention and related testing or treatment protocols.",
"modified": [
"Expands pharmacist capacity to participate in HIV prevention strategies per protocol or CPAs; documentation required."
]
},
"citation": "151.37",
"subdivision": "subdivision 17"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References telemedicine as defined under Minnesota Statutes; used in context of pharmacist vaccination and testing under protocol regimes.",
"modified": [
"Incorporates telehealth framework in the pharmacist practice and vaccine administration contexts."
]
},
"citation": "62A.673",
"subdivision": "subdivision 2"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References the opiate antagonist prescribing protocols as defined in Minnesota Statutes section 604A.04, subdivision 1, within the pharmacy practice framework.",
"modified": [
"Links to opioid antagonist protocols as part of protocol-based drug therapy management."
]
},
"citation": "604A.04",
"subdivision": "subdivision 1"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References to Minnesota Statutes chapter 147A related to prescribing, dispensing and administering under pharmacist practice; context for CPA and interprofessional collaboration.",
"modified": [
"Pharmacist authority activities tied to Chapter 147A prescribing and dispensing provisions."
]
},
"citation": "147A",
"subdivision": ""
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References Minnesota Statutes section 148.235 providing guidelines to dentists performing vaccinations.",
"modified": []
},
"citation": "148.235",
"subdivision": ""
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "Cites the Federal CFR provision defining shoulder injury related to vaccine administration (SIRVA) for purposes of the SIRVA-related training and poster requirements.",
"modified": []
},
"citation": "42 CFR 100.3c10",
"subdivision": ""
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "Cites the federal CLIA Act statutory framework (as referenced) for waived testing performed by pharmacists.",
"modified": []
},
"citation": "42 U.S.C. § 263a et seq.",
"subdivision": ""
}
]Progress through the legislative process
In Committee